$SHWZ
Medicine Man Technologies, Inc.

2023 Q2 Form 10-Q Financial Statement

#000155837023009230 Filed on May 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $42.38M $40.00M $31.78M
YoY Change -4.27% 25.88% 64.31%
Cost Of Revenue $17.86M $16.97M $20.84M
YoY Change -6.55% -18.58% 72.42%
Gross Profit $24.52M $23.03M $10.94M
YoY Change -2.53% 110.58% 50.8%
Gross Profit Margin 57.86% 57.58% 34.42%
Selling, General & Admin $8.839M $10.22M $15.73M
YoY Change 32.6% -35.05% 80.0%
% of Gross Profit 36.05% 44.35% 143.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.127M $6.151M $2.541M
YoY Change 209.38% 142.1% 41.9%
% of Gross Profit 4.6% 26.71% 23.23%
Operating Expenses $19.56M $17.38M $15.73M
YoY Change 21.34% 10.52% 80.0%
Operating Profit $4.957M $5.650M -$4.791M
YoY Change -45.14% -217.94% 222.62%
Interest Expense -$6.422M $757.7K -$20.73M
YoY Change -121.99% -103.66% 936.18%
% of Operating Profit -129.55% 13.41%
Other Income/Expense, Net -$6.422M $757.6K $10.00
YoY Change -121.99% 7576370.0%
Pretax Income -$1.465M $6.408M -$25.52M
YoY Change -103.83% -125.11% 699.24%
Income Tax $5.143M $4.662M $1.260M
% Of Pretax Income 72.76%
Net Earnings -$6.608M $1.745M -$26.78M
YoY Change -119.53% -106.52% 633.76%
Net Earnings / Revenue -15.59% 4.36% -84.27%
Basic Earnings Per Share -$0.15 -$0.01 -$0.61
Diluted Earnings Per Share -$0.15 -$0.06 -$571.7K
COMMON SHARES
Basic Shares Outstanding 55.56M 55.21M 46.84M
Diluted Shares Outstanding 60.54M 101.6M 46.84M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.33M $35.62M $47.69M
YoY Change -39.97% -25.3% 107.64%
Cash & Equivalents $19.87M $35.17M $47.69M
Short-Term Investments $456.1K $456.1K
Other Short-Term Assets $6.203M $8.330M $3.008M
YoY Change -32.63% 176.9% 379.78%
Inventory $33.82M $25.58M $16.38M
Prepaid Expenses
Receivables $6.180M $4.590M $4.197M
Other Receivables $0.00 $0.00 $107.5K
Total Short-Term Assets $66.53M $74.12M $71.38M
YoY Change -0.41% 3.84% 125.98%
LONG-TERM ASSETS
Property, Plant & Equipment $31.13M $29.33M $30.32M
YoY Change 48.54% -3.27% 313.61%
Goodwill $75.97M $64.48M $118.7M
YoY Change -29.64% -45.68%
Intangibles $168.9M $132.4M
YoY Change
Long-Term Investments $2.000M $2.000M $485.0K
YoY Change 316.89% 312.37% -1.3%
Other Assets $1.223M $1.167M -$3.815M
YoY Change -16.48% -130.58% -1000.29%
Total Long-Term Assets $302.4M $249.3M $246.6M
YoY Change 20.32% 1.07% 65.04%
TOTAL ASSETS
Total Short-Term Assets $66.53M $74.12M $71.38M
Total Long-Term Assets $302.4M $249.3M $246.6M
Total Assets $369.0M $323.4M $318.0M
YoY Change 15.97% 1.69% 75.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.11M $4.259M $3.207M
YoY Change 275.59% 32.8% 27.11%
Accrued Expenses $6.398M $10.41M $1.011M
YoY Change -28.65% 930.43% -27.95%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $134.5K
YoY Change -100.0%
Long-Term Debt Due $6.583M $3.000M
YoY Change
Total Short-Term Liabilities $49.77M $41.97M $70.28M
YoY Change 74.28% -40.28% 435.56%
LONG-TERM LIABILITIES
Long-Term Debt $148.9M $128.2M $117.9M
YoY Change 22.94% 8.76% 117.26%
Other Long-Term Liabilities $22.10M $19.11M $14.08M
YoY Change 91.6% 35.69% 224.33%
Total Long-Term Liabilities $171.1M $147.3M $131.9M
YoY Change 29.05% 11.63% 125.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $49.77M $41.97M $70.28M
Total Long-Term Liabilities $171.1M $147.3M $131.9M
Total Liabilities $220.9M $189.3M $202.2M
YoY Change 37.06% -6.41% 181.99%
SHAREHOLDERS EQUITY
Retained Earnings -$51.10M -$44.50M
YoY Change 146.74%
Common Stock $71.73K $56.35K
YoY Change 28.1%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.033M $2.033M
YoY Change 2.13%
Treasury Stock Shares
Shareholders Equity $148.1M $134.1M $115.8M
YoY Change
Total Liabilities & Shareholders Equity $369.0M $323.4M $318.0M
YoY Change 15.97% 1.69% 75.68%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$6.608M $1.745M -$26.78M
YoY Change -119.53% -106.52% 633.76%
Depreciation, Depletion And Amortization $1.127M $6.151M $2.541M
YoY Change 209.38% 142.1% 41.9%
Cash From Operating Activities $2.683M -$879.9K $5.831M
YoY Change -119.45% -115.09% 243.3%
INVESTING ACTIVITIES
Capital Expenditures $1.791M $2.913M -$2.608M
YoY Change -140.7% -211.73% 311.87%
Acquisitions
YoY Change
Other Investing Activities -$15.83M $10.63K -$90.32M
YoY Change 183.46% -100.01% 39.02%
Cash From Investing Activities -$17.63M -$2.903M -$92.92M
YoY Change 76.5% -96.88% 41.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -352.9K 28.38M
YoY Change -103.55% -66.86%
NET CHANGE
Cash From Operating Activities 2.683M -879.9K 5.831M
Cash From Investing Activities -17.63M -2.903M -92.92M
Cash From Financing Activities -352.9K 28.38M
Net Change In Cash -15.29M -3.783M -58.71M
YoY Change 10.62% -93.56% -370.2%
FREE CASH FLOW
Cash From Operating Activities $2.683M -$879.9K $5.831M
Capital Expenditures $1.791M $2.913M -$2.608M
Free Cash Flow $892.7K -$3.793M $8.439M
YoY Change -109.5% -144.95% 261.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2138847
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
86994
CY2023Q1 shwz Escrow Shares
EscrowShares
944
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
86994
CY2022Q4 shwz Escrow Shares
EscrowShares
944
CY2023Q1 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
CY2023Q1 us-gaap Preferred Stock Dividend Rate Per Dollar Amount
PreferredStockDividendRatePerDollarAmount
1000
CY2023Q1 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
1.20
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001622879
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-55450
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
MEDICINE MAN TECHNOLOGIES, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5289499
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4880 Havana Street
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 201
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Denver
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80239
CY2023Q1 dei City Area Code
CityAreaCode
(303)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
371-0387
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55561244
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35166629
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38949253
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4590159
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4471978
CY2023Q1 us-gaap Inventory Net
InventoryNet
25577433
CY2022Q4 us-gaap Inventory Net
InventoryNet
22554182
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
11944
CY2023Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
1816
CY2022 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
39270
CY2023Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
456099
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
454283
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8330194
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5293393
CY2023Q1 us-gaap Assets Current
AssetsCurrent
74120514
CY2022Q4 us-gaap Assets Current
AssetsCurrent
71735033
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5880513
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4899977
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29332369
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27089026
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
2000000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
2000000
CY2023Q1 us-gaap Goodwill
Goodwill
64479817
CY2022Q4 us-gaap Goodwill
Goodwill
94605301
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21461721
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16290862
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
132370859
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
107726718
CY2023Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1313
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
135155
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1166582
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1527256
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19783067
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18199399
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
249269162
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
251147700
CY2023Q1 us-gaap Assets
Assets
323389676
CY2022Q4 us-gaap Assets
Assets
322882733
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4258510
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7848613
CY2023Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
48276
CY2022Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
22380
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10414494
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10314958
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
8006568
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
16508253
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3648395
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3139289
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
3000000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2250000
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
12597218
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
7297815
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
41973461
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
47381308
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
128184150
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
125521520
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19108720
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17314464
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
502070
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
147292870
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
143338054
CY2023Q1 us-gaap Liabilities
Liabilities
189266331
CY2022Q4 us-gaap Liabilities
Liabilities
190719362
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
86994
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
86994
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
86994
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
86994
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
87
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
87
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56352545
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55212547
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56352545
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55212547
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
56353
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
56353
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
180596185
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
180381641
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44496153
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46241583
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
920150
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
920150
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
2033127
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2033127
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
134123345
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
132163371
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
323389676
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
322882733
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40000936
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31777554
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
16968270
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
20840051
CY2023Q1 us-gaap Gross Profit
GrossProfit
23032666
CY2022Q1 us-gaap Gross Profit
GrossProfit
10937503
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10215805
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6855711
CY2023Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
1187364
CY2022Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
2584472
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
5764993
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
5296777
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
214544
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
991083
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
17382706
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
15728043
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
5649960
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4790540
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7745854
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7302254
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
8501685
CY2022Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-13417472
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
1816
CY2022Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-8549
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
757647
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-20728268
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6407607
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25518808
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4662178
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1259894
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1745429
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-26778702
CY2023Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
2029394
CY2022Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1743444
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-283965
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28522146
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55835501
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46841971
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101608278
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46841971
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1745429
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26778702
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
133569665
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-26778702
CY2022Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
13200000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
991083
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
120982046
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
132163371
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1745429
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
214544
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
134123345
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1745429
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-26778702
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6151395
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2540796
CY2023Q1 shwz Non Cash Interest Expenses
NonCashInterestExpenses
991184
CY2022Q1 shwz Non Cash Interest Expenses
NonCashInterestExpenses
1203333
CY2023Q1 shwz Noncash Lease Expense
NoncashLeaseExpense
2251459
CY2022Q1 shwz Noncash Lease Expense
NoncashLeaseExpense
1079913
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
637225
CY2023Q1 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
8501685
CY2022Q1 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-13417472
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
421513
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
421512
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1999933
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1756173
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
1816
CY2022Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-8549
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
214544
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
991083
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
118181
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
120388
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3023251
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6628633
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3036801
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-104888
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-360674
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
867401
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1531765
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-921947
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-3464671
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
2898513
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5299403
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1259894
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-879861
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3622321
CY2023Q1 us-gaap Proceeds From Collection Of Finance Receivables
ProceedsFromCollectionOfFinanceReceivables
10631
CY2022Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
59691039
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2913394
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2643404
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2902763
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-62334443
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3782624
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-58712122
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38949253
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106400216
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35166629
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2029394
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47688094
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
6540748
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
4722639
CY2023Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
3160499
CY2022Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
5921148
CY2022Q1 shwz Settling Of Note Receivable In Exchange For Equipment
SettlingOfNoteReceivableInExchangeForEquipment
35833
CY2022Q1 shwz Issuance Of Debt For Acquisition
IssuanceOfDebtForAcquisition
17000000
CY2022Q1 shwz Issuance Of Stock As Payments For Acquisitions
IssuanceOfStockAsPaymentsForAcquisitions
13200000
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
153832580
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21461721
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
124017580
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16290862
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5170859
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
1506435
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2325482
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
16215540
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
14504490
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7855458
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5724210
CY2023Q1 us-gaap Inventory Net
InventoryNet
25577433
CY2022Q4 us-gaap Inventory Net
InventoryNet
22554182
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
35212882
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
31989003
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5880513
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4899977
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29332369
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27089026
CY2023Q1 us-gaap Depreciation
Depreciation
980536
CY2022Q1 us-gaap Depreciation
Depreciation
401949
CY2022Q4 us-gaap Goodwill
Goodwill
94605301
CY2023Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-30125484
CY2023Q1 us-gaap Goodwill
Goodwill
64479817
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
11719306
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q4 us-gaap Goodwill
Goodwill
43316267
CY2022Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
75382450
CY2022Q1 us-gaap Goodwill
Goodwill
118698717
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
10574128
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
11795636
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
11502223
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
10634720
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
10125611
CY2023Q1 shwz Finite Lived Intangible Asset Amortization Expense After Year Four
FiniteLivedIntangibleAssetAmortizationExpenseAfterYearFour
77738541
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
132370859
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
34923013
CY2022Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
13417472
CY2022Q1 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
48340485
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
16508253
CY2023Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-8501685
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
8006568
CY2023Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
6182181
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
6603695
CY2023Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
38993243
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
40993176
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
131184150
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
127771520
CY2023Q1 shwz Less Current Portion Of Long Term Debt
LessCurrentPortionOfLongTermDebt
-3000000
CY2022Q4 shwz Less Current Portion Of Long Term Debt
LessCurrentPortionOfLongTermDebt
-2250000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
128184150
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
125521520
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
2250000
CY2023Q1 shwz Long Term Debt Unamortized Debt Issuance Costs Remainder Of Fiscal Year
LongTermDebtUnamortizedDebtIssuanceCostsRemainderOfFiscalYear
1264535
CY2023Q1 shwz Long Term Debt Unamortized Debt Discount Remainder Of Fiscal Year
LongTermDebtUnamortizedDebtDiscountRemainderOfFiscalYear
6523560
CY2023Q1 shwz Total Long Term Debt Remainder Of Fiscal Year
TotalLongTermDebtRemainderOfFiscalYear
-5538095
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3000000
CY2023Q1 shwz Long Term Debt Unamortized Debt Issuance Costs Year One
LongTermDebtUnamortizedDebtIssuanceCostsYearOne
1686049
CY2023Q1 shwz Long Term Debt Unamortized Debt Discount Year One
LongTermDebtUnamortizedDebtDiscountYearOne
9734935
CY2023Q1 shwz Total Long Term Debt Year One
TotalLongTermDebtYearOne
-8420984
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
40651759
CY2023Q1 shwz Long Term Debt Unamortized Debt Issuance Costs Year Two
LongTermDebtUnamortizedDebtIssuanceCostsYearTwo
1686049
CY2023Q1 shwz Long Term Debt Unamortized Debt Discount Year Two
LongTermDebtUnamortizedDebtDiscountYearTwo
11057799
CY2023Q1 shwz Total Long Term Debt Year Two
TotalLongTermDebtYearTwo
27907911
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
130457815
CY2023Q1 shwz Long Term Debt Unamortized Debt Issuance Costs Year Three
LongTermDebtUnamortizedDebtIssuanceCostsYearThree
1545548
CY2023Q1 shwz Long Term Debt Unamortized Debt Discount Year Three
LongTermDebtUnamortizedDebtDiscountYearThree
11676949
CY2023Q1 shwz Total Long Term Debt Year Three
TotalLongTermDebtYearThree
117235318
CY2023Q1 shwz Long Term Debt Maturities Repayments Of Principal
LongTermDebtMaturitiesRepaymentsOfPrincipal
176359574
CY2023Q1 shwz Long Term Debt Unamortized Debt Issuance Costs
LongTermDebtUnamortizedDebtIssuanceCosts
6182181
CY2023Q1 shwz Long Term Debt Unamortized Debt Discount
LongTermDebtUnamortizedDebtDiscount
38993243
CY2023Q1 shwz Total Long Term Debt
TotalLongTermDebt
131184150
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19783067
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3648395
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19108720
CY2023Q1 shwz Lessee Operating Lease Liability Payments Due Next Twelve Months1
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths1
35528050
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12250813
CY2023Q1 shwz Present Value Of Lease Liabilities
PresentValueOfLeaseLiabilities
23277237
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4730948
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5343579
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4976285
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4496205
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3215732
CY2023Q1 shwz Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
12765301
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
35528050
CY2023Q1 shwz Number Of Classes Of Stock
NumberOfClassesOfStock
2
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1743444
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56352545
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55212547
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
920150
CY2023Q1 shwz Common Stock Held In Escrow
CommonStockHeldInEscrow
441247
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56352545
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55212547
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
920150
CY2022 shwz Common Stock Held In Escrow
CommonStockHeldInEscrow
219848
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
214544
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
991083
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1745429
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-26778702
CY2023Q1 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
2029394
CY2022Q1 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
1743444
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-283965
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28522146
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55835501
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46841971
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-283965
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28522146
CY2023Q1 shwz Add Investor Note Accrued Interest
AddInvestorNoteAccruedInterest
421514
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1999933
CY2023Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-8501685
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6364203
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-28522146
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55835501
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46841971
CY2023Q1 shwz Dilutive Effect Of Investor Notes
DilutiveEffectOfInvestorNotes
45772777
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101608278
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46841971
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6407607
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25518808
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4662178
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1259894
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.7276
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0494
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001558370-23-009230-index-headers.html Edgar Link pending
0001558370-23-009230-index.html Edgar Link pending
0001558370-23-009230.txt Edgar Link pending
0001558370-23-009230-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
shwz-20230331.xsd Edgar Link pending
shwz-20230331x10q.htm Edgar Link pending
shwz-20230331xex2d3.htm Edgar Link pending
shwz-20230331xex31d1.htm Edgar Link pending
shwz-20230331xex31d2.htm Edgar Link pending
shwz-20230331xex32.htm Edgar Link pending
shwz-20230331_cal.xml Edgar Link unprocessable
shwz-20230331_def.xml Edgar Link unprocessable
shwz-20230331_lab.xml Edgar Link unprocessable
shwz-20230331_pre.xml Edgar Link unprocessable
shwz-20230331x10q_htm.xml Edgar Link completed